Previous Article | Next Article ![]()
J. Virol., Sep 1996, 5867-5874, Vol 70, No. 9
CW Beard and KR Spindler
Early region 3 (E3) of mouse adenovirus type 1 has the potential to produce
three proteins which have identical amino termini but unique
carboxy-terminal sequences. Three recombinant deletion viruses were
constructed so that each could produce only one of the three E3 proteins. A
fourth mutant that should produce no E3 proteins was also constructed.
These recombinants were able to grow in mouse 3T6 cells and produced
wild-type levels of viral mRNAs and proteins except for those specifically
deleted by the mutations. Early mRNA production from the mutant viruses was
analyzed by reverse transcriptase PCR and confirmed that each deletion
mutant would be able to produce only one of the three E3 proteins. Late
mRNA production was analyzed by Northern (RNA) blotting and found to be
similar in wild-type and mutant viruses. Capsid morphology was unaltered in
the mutant viruses as seen by electron microscopy. Immunoprecipitation of
E3 proteins from infections of mouse 3T6 cells using an antiserum specific
for all three E3 proteins was used to examine the effect of the introduced
mutations on protein expression. Two mutants produced only one class of E3
protein as predicted from their specific mutations and mRNA expression
profiles. One mutant virus failed to produce any detectable E3 proteins.
The predicted E3-null mutant was found to be leaky and could produce low
levels of E3 proteins. Outbred Swiss mice were infected with the E3 mutant
viruses to determine if the E3 proteins have an effect on the pathogenicity
of the virus in mice. All of the mutants showed decreased pathogenicity as
determined by increased 50% lethal doses, indicating that the proteins of
the E3 region are important determinants of the pathogenesis of mouse
adenovirus in its natural host.
Copyright © 1996, American Society for Microbiology
Analysis of early region 3 mutants of mouse adenovirus type 1
Department of Genetics, University of Georgia, Athens 30602, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|